Vol 5, No 8 (2025)

decorative image of the issue cover

Reimbursement Recommendations

Relugolix–Estradiol–Norethindrone Acetate (Myfembree)

CDA-AMC

Published August 29, 2025

PDF HTML ePub

Durvalumab (Imfinzi)

CDA-AMC

Published August 27, 2025

PDF HTML ePub

Ruxolitinib (Opzelura)

CDA-AMC

Published August 25, 2025

PDF HTML ePub

Trofinetide (Daybue)

CDA-AMC

Published August 22, 2025

PDF HTML ePub

Nivolumab

CDA-AMC

Published August 13, 2025

PDF HTML ePub

Quizartinib (Vanflyta)

CDA-AMC

Published August 11, 2025

PDF HTML ePub

Crovalimab (Piasky)

CDA-AMC

Published August 7, 2025

PDF HTML ePub

Cipaglucosidase Alfa (Pombiliti) With Miglustat (Opfolda)

CDA-AMC

Published August 7, 2025

PDF HTML ePub

Dupilumab (Dupixent)

CDA-AMC

Published August 6, 2025

PDF HTML ePub

Dupilumab (Dupixent)

CDA-AMC

Published August 5, 2025

PDF HTML ePub

Reimbursement Reviews

Pemigatinib (Pemazyre)

CDA-AMC

Published August 25, 2025

PDF HTML ePub

Daratumumab (Darzalex SC)

CDA-AMC

Published August 21, 2025

PDF HTML ePub

Nivolumab

CDA-AMC

Published August 5, 2025

PDF HTML ePub

Health Technology Reviews

Portable CT for Use in the Hospital

CDA-AMC

Published August 26, 2025

PDF HTML ePub

View All Issues